Literature DB >> 21862274

An academic-marketing collaborative to promote depression care: a tale of two cultures.

Richard L Kravitz1, Ronald M Epstein, Robert A Bell, Aaron B Rochlen, Paul Duberstein, Caroline H Riby, Anthony F Caccamo, Christina K Slee, Camille S Cipri, Debora A Paterniti.   

Abstract

OBJECTIVES: Commercial advertising and patient education have separate theoretical underpinnings, approaches, and practitioners. This paper aims to describe a collaboration between academic researchers and a marketing firm working to produce demographically targeted public service anouncements (PSAs) designed to enhance depression care-seeking in primary care.
METHODS: An interdisciplinary group of academic researchers contracted with a marketing firm in Rochester, NY to produce PSAs that would help patients with depressive symptoms engage more effectively with their primary care physicians (PCPs). The researchers brought perspectives derived from clinical experience and the social sciences and conducted empirical research using focus groups, conjoint analysis, and a population-based survey. Results were shared with the marketing firm, which produced four PSA variants targeted to gender and socioeconomic position.
RESULTS: There was no simple, one-to-one relationship between research results and the form, content, or style of the PSAs. Instead, empirical findings served as a springboard for discussion and kept the creative process tethered to the experiences, attitudes, and opinions of actual patients. Reflecting research findings highlighting patients' struggles to recognize, label, and disclose depressive symptoms, the marketing firm generated communication objectives that emphasized: (a) educating the patient to consider and investigate the possibility of depression; (b) creating the belief that the PCP is interested in discussing depression and capable of offering helpful treatment; and (c) modelling different ways of communicating with physicians about depression. Before production, PSA prototypes were vetted with additional focus groups. The winning prototype, "Faces," involved a multi-ethnic montage of formerly depressed persons talking about how depression affected them and how they improved with treatment, punctuated by a physician who provided clinical information. A member of the academic team was present and consulted closely during production. Challenges included reconciling the marketing tradition of audience segmentation with the overall project goal of reaching as broad an audience as possible; integrating research findings across dimensions of words, images, music, and tone; and dealing with misunderstandings related to project scope and budget.
CONCLUSION: Mixed methods research can usefully inform PSAs that incorporate patient perspectives and are produced to professional standards. However, tensions between the academic and commercial worlds exist and must be addressed. PRACTICE IMPLICATIONS: While rewarding, academic-marketing collaborations introduce tensions which must be addressed.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21862274      PMCID: PMC3235260          DOI: 10.1016/j.pec.2011.07.003

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  33 in total

Review 1.  Direct-to-consumer prescription drug advertising: trends, impact, and implications.

Authors:  M S Wilkes; R A Bell; R L Kravitz
Journal:  Health Aff (Millwood)       Date:  2000 Mar-Apr       Impact factor: 6.301

2.  On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs.

Authors:  M B Pinto
Journal:  Psychol Rep       Date:  2000-04

3.  Have drug companies hyped social anxiety disorder to increase sales. Yes: marketing hinders discovery of long-term solutions.

Authors:  D Healy
Journal:  West J Med       Date:  2001-12

4.  Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey.

Authors:  Barbara Mintzes; Morris L Barer; Richard L Kravitz; Arminée Kazanjian; Ken Bassett; Joel Lexchin; Robert G Evans; Richard Pan; Stephen A Marion
Journal:  BMJ       Date:  2002-02-02

5.  Mass media antismoking campaigns: a powerful tool for health promotion.

Authors:  M Siegel
Journal:  Ann Intern Med       Date:  1998-07-15       Impact factor: 25.391

6.  Direct-to-consumer prescription drug advertising and the public.

Authors:  R A Bell; R L Kravitz; M S Wilkes
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

7.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

8.  Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes.

Authors:  S Greenfield; S H Kaplan; J E Ware; E M Yano; H J Frank
Journal:  J Gen Intern Med       Date:  1988 Sep-Oct       Impact factor: 5.128

9.  Expanding patient involvement in care. Effects on patient outcomes.

Authors:  S Greenfield; S Kaplan; J E Ware
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

10.  How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.

Authors:  Barbara Mintzes; Morris L Barer; Richard L Kravitz; Ken Bassett; Joel Lexchin; Arminée Kazanjian; Robert G Evans; Richard Pan; Stephen A Marion
Journal:  CMAJ       Date:  2003-09-02       Impact factor: 8.262

View more
  4 in total

1.  The effect of targeted and tailored patient depression engagement interventions on patient-physician discussion of suicidal thoughts: a randomized control trial.

Authors:  Ruby Shah; Peter Franks; Anthony Jerant; Mitchell Feldman; Paul Duberstein; Erik Fernandez y Garcia; Ladson Hinton; Lorrie Strohecker; Richard L Kravitz
Journal:  J Gen Intern Med       Date:  2014-04-08       Impact factor: 5.128

2.  Learning from marketing: Rapid development of medication messages that engage patients.

Authors:  Veronica Yank; Erika Tribett; Lydia Green; Jasmine Pettis
Journal:  Patient Educ Couns       Date:  2015-03-14

3.  Patient engagement programs for recognition and initial treatment of depression in primary care: a randomized trial.

Authors:  Richard L Kravitz; Peter Franks; Mitchell D Feldman; Daniel J Tancredi; Christina A Slee; Ronald M Epstein; Paul R Duberstein; Robert A Bell; Maga Jackson-Triche; Debora A Paterniti; Camille Cipri; Ana-Maria Iosif; Sarah Olson; Steven Kelly-Reif; Andrew Hudnut; Simon Dvorak; Charles Turner; Anthony Jerant
Journal:  JAMA       Date:  2013-11-06       Impact factor: 56.272

4.  Targeted versus tailored multimedia patient engagement to enhance depression recognition and treatment in primary care: randomized controlled trial protocol for the AMEP2 study.

Authors:  Daniel J Tancredi; Christina K Slee; Anthony Jerant; Peter Franks; Jasmine Nettiksimmons; Camille Cipri; Dustin Gottfeld; Julia Huerta; Mitchell D Feldman; Maja Jackson-Triche; Steven Kelly-Reif; Andrew Hudnut; Sarah Olson; Janie Shelton; Richard L Kravitz
Journal:  BMC Health Serv Res       Date:  2013-04-17       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.